Dr. Christina Allen is a Professor of Orthopaedics & Rehabilitation at Yale School of Medicine, where she serves as Chief of Yale Sports Medicine and Vice Chair of Athletic Medicine and Community Outreach. She is the Orthopaedic Team Physician for Yale Athletics and has extensive experience with U.S. national teams, including U.S. Soccer and USA Taekwondo. Education: BS in Biomedical Engineering, Duke University (1983); MD, UCLA School of Medicine (1995) Training: Orthopaedic Residency and Sports Medicine Fellowship, University of Pittsburgh Research Interests focus on: Revision ACL reconstruction outcomes and predictors Meniscus transplantation and cartilage repair Proximal hamstring avulsion repair Quantitative MRI for joint kinematics and cartilage changes Post-ACL revision infection risk factors Scientific Awards include: Kappa Delta Ann Doner Vaughn Award (2019) NIH R01 Competitive Renewal Grant (2017) AOSSM O’Donoghue Award (2014) Clinical Roles span: Team physician for U.S. Soccer (Women's/Men's National Teams) Former team physician for San Francisco Deltas (NASL Champions 2017) Medical Board member, World Taekwondo (London Olympics 2012, Rio Olympics 2016) Publications highlight a 20-year longitudinal focus on: Machine learning models for surgical outcome prediction Graft choice impact on revision ACL longevity Cartilage degeneration after meniscectomy Biomechanical MRI analysis of joint kinematics Infection rates in revision surgeries Return-to-sport protocols for athletes
Anastassios Karistinos, M.D., is an Assistant Professor in the Department of Orthopedic Surgery at Baylor College of Medicine. He holds clinical roles at Ben Taub Hospital, Baylor Clinic, and the Michael E. DeBakey VA Medical Center in Houston, Texas. Dr. Karistinos completed his medical degree (MD) at Aristotle University of Thessaloniki (1993), followed by residency at Louisiana State University Health Sciences Center (2005) and a fellowship in Advanced Orthopaedics and Sports Medicine (2005). His professional interests focus on complex musculoskeletal conditions including multi-ligament knee injuries, meniscal transplantation, cartilage restoration techniques (OATS, ACI), knee osteotomies, shoulder instability, rotator cuff injuries, and shoulder arthroplasty. He emphasizes patient safety and critical evaluation of emerging medical technologies, prioritizing evidence-based treatments. Dr. Karistinos is certified by the American Board of Orthopaedic Surgery in both Orthopaedic Surgery and Orthopaedic Sports Medicine. He is a Fellow of the American Academy of Orthopaedic Surgeons and specializes in sports medicine, arthroscopic surgery, and trauma care. His research integrates anatomical insights with clinical outcomes to improve surgical techniques and patient recovery processes.
Brendan A. Harley is the Robert W. Schaefer Professor in Chemical and Biomolecular Engineering at the University of Illinois at Urbana-Champaign (UIUC), with a joint appointment in the Carl R. Woese Institute for Genomic Biology. His research focuses on developing biomaterials to replicate complex tissue microenvironments, enabling insights into cell behavior during development, disease, and regeneration. He holds leadership roles in academic and professional organizations, including editorial positions for Science Advances and Tissue Engineering . Harley earned his SB from Harvard University (2000), SM/ScD from MIT (2002, 2006), and completed postdoctoral studies at Boston Children’s Hospital. **Education**: Sc.D., Massachusetts Institute of Technology, 2006 S.M., Massachusetts Institute of Technology, 2002 S.B., Harvard University, 2000 **Research Interests**: Engineering dynamic, spatially-patterned biomaterials to mimic extracellular matrices Regenerative repair of musculoskeletal tissues Biomaterial models of cancer microenvironments (e.g., glioblastoma) Artificial bone marrow systems for hematopoietic stem cell studies Harley’s work has produced over 100 peer-reviewed articles and co-authored a textbook Cellular Materials in Nature and Medicine . His lab develops materials for clinical applications, including osteochondral defect repair and craniofacial bone regeneration. Notable honors include the NSF CAREER Award (2013), AAAS Fellowship (2014), and AIMBE Fellowship (2019). **Awards/Recognition**: Fellow, AAAS (2014) Young Investigator Award, Society for Biomaterials (2014) Campus Distinguished Promotion Award, UIUC (2018) His research group emphasizes translational outcomes, with projects spanning biomaterial design, cancer modeling, and stem cell engineering. Collaborations include industry partners like Orthomimetics (acquired by TiGenix) and foundational studies on tumor microenvironments.
Woojin Han is an Assistant Professor in the Departments of Orthopedics and Cell, Developmental & Regenerative Biology at the Icahn School of Medicine at Mount Sinai. His research program focuses on the mechanobiology of skeletal muscle stem and progenitor cells, with applications in disease modeling and the development of advanced therapeutics for muscle injuries and degenerative diseases. Dr. Han earned his BS in Biomedical Engineering from the University of Rochester and his MS and PhD in Bioengineering from the University of Pennsylvania. He completed his postdoctoral training at the Georgia Institute of Technology, where he received awards from the American Federation for Aging Research (AFAR) and the NIH. Dr. Han's research integrates biomaterials, bioengineering, and in vivo genetic approaches to investigate cell-matrix interactions and mechanobiological signaling, aiming to uncover the mechanisms driving muscle regeneration and pathology. His work is supported by the National Institutes of Health (NIH) and the Department of Defense (DoD). Analysis of Dr. Han's recent publications reveals a strong focus on muscle regeneration mechanisms, particularly examining the role of extracellular matrix proteins, mechanical confinement, and signaling pathways in muscle stem cell behavior. His research spans from fundamental mechanobiology to translational applications using biomaterials for tissue regeneration. 2025 NEBEC Emerging Investigator Award 2024 Mount Sinai Faculty Council Award for Junior Faculty 2023 Popular Science's The Brilliant 10 2022 Stephen I. Katz Early Stage Investigator Grant Awardee American Federation for Aging Research (AFAR) award NIH award Dr. Han's research is supported by significant funding from the National Institutes of Health (NIH) and the Department of Defense (DoD). His work bridges basic science and clinical applications, with particular emphasis on developing advanced therapeutics for muscle injuries and degenerative diseases. Through his lab, he mentors junior researchers in the fields of biomechanics, bioengineering, and regenerative medicine. Dr. Han leads the Han Lab, which focuses on skeletal muscle regeneration research. The lab employs a multidisciplinary approach combining biomaterials engineering, molecular biology, and advanced imaging techniques to develop novel strategies for enhancing muscle repair and preventing pathological changes following injury.
Lou J. Soslowsky is the Fairhill Professor at the University of Pennsylvania, serving as Director of Orthopaedic Research, Director of Basic Science Research for the Shoulder and Elbow Service, and Vice Chair for Research in the Department of Orthopaedic Surgery at the Perelman School of Medicine. He was reappointed to the Vice Chair position in 2024, demonstrating his continued leadership role. Dr. Soslowsky is also the Founding Director of the Penn Center for Musculoskeletal Disorders (designated as a Type 1 center in 2008) and an Associate Dean for Research Integration at the Perelman School of Medicine. Dr. Soslowsky earned his B.S. (1986), M.S. (1987), M.Phil (1989), and Ph.D. (1991) in Engineering Mechanics from Columbia University, with doctoral research mentored by Van C. Mow. He later obtained a certificate in Academic Medicine Leadership from the Wharton School of the University of Pennsylvania in 2008. Dr. Soslowsky's research focuses on the biomechanics of tendons and ligaments, particularly in the shoulder and elbow. His laboratory investigates the structural, functional, and molecular properties of musculoskeletal tissues, examining how these tissues respond to injury, healing, and aging. Current projects examine collagen organization (particularly Collagen V and XI), the role of decorin and biglycan in tendon healing, exercise effects on tendon adaptation, and advanced imaging techniques for monitoring tissue changes. His work integrates engineering principles with biological approaches to understand tissue mechanics and develop therapeutic strategies for musculoskeletal disorders. His recent publications (2024-2025) demonstrate a strong focus on tendon biology and biomechanics, with particular attention to molecular regulation of tendon healing, collagen organization, and the effects of aging and mechanical loading. His research spans from basic molecular mechanisms to translational applications, often utilizing murine models to investigate tendon development, injury, and repair processes. The interdisciplinary nature of his work bridges engineering, biology, and clinical orthopaedics. Founding Director, Penn Center for Musculoskeletal Disorders (Type 1 center designation, 2008) Fellow, Institute of Aging, University of Pennsylvania Executive Committee, Department of Bioengineering, University of Pennsylvania As Director of the McKay Orthopaedic Research Laboratory, Dr. Soslowsky oversees an active research program with publications spanning from 1987 to 2025 (274 PubMed-listed publications). His laboratory serves as a hub for interdisciplinary research in orthopaedic biomechanics and tissue engineering, bringing together engineers, biologists, and clinicians to address fundamental questions in musculoskeletal science. His work has significant translational implications for understanding and treating tendon injuries, which are common clinical problems affecting millions of people.
Prof. Stephen J. Ferguson is a Full Professor at ETH Zurich's Department of Health Sciences and Technology and Head of the Institute for Biomechanics. His research focuses on musculoskeletal biomechanics, biomaterials, and implant technologies addressing aging-related health challenges. He holds a Venia Docendi in Musculoskeletal Biomechanics and has led the Biomechanics Division at the University of Bern. Key honors include the ETH Golden Owl (2021) and ESB Clinical Biomechanics Award (2022). Education: Bachelor of Mechanical Engineering, University of Toronto (1991) Master's, Queen's University (1994) PhD, Queen's University (2000) Postdoc, University of Bern (2000-2002) Research Interests: Biomaterials for implants, musculoskeletal disorder mechanisms, computational biomechanics, and translational medical devices. Awards: ESB Clinical Biomechanics Award (2022) ETH Golden Owl (2021) European Spine Journal GRAMMER prize (2009) CTI Medtech Award (2005) Professional Activities: Five patent applications, course leadership in Biomedical Engineering and Spine Research, and director roles at ARTORG Spine Research Center. Labs/Teams: Leads the Institute for Biomechanics at ETH Zurich, focusing on cutting-edge biomechanical research and clinical translation.
H. Paco Kang, MD, is a Clinical Assistant Professor of Orthopaedic Surgery at the University of Southern California's Keck School of Medicine. He specializes in musculoskeletal oncology, treating benign and malignant tumors in the pelvis and extremities while managing skeletal metastases in lung, breast, and thyroid cancer patients. He practices at USC Norris Comprehensive Cancer Center within Keck Medicine of USC, collaborating with multidisciplinary teams. Education: MD from Columbia University Fellowship: Musculoskeletal Oncology at Harvard Medical School Dr. Kang's clinical research focuses on improving functional outcomes and survival for metastatic cancer patients through innovations like carbon-fiber implants, 3D-printed reconstructions, and robotic surgery. His recent publications highlight trends in technology-assisted arthroplasty, surgical complications in orthopaedic oncology, and outcomes in sports medicine procedures. His work spans areas such as: Robotic and navigation-assisted joint replacements Functional outcome metrics for sarcoma patients Anticoagulation safety in arthroplasty Biomechanical risk factors in postoperative stability Impact of preoperative imaging on surgical planning
Michael A. Barry, Ph.D., is a Professor of Medicine at Mayo Clinic in Rochester, Minnesota, where he holds primary and joint appointments as a Consultant in the Department of Internal Medicine (Division of Infectious Diseases), Department of Immunology, and Department of Molecular Medicine. He leads the Virology, Vector and Vaccine Engineering Laboratory, focusing on developing advanced gene therapies, viral vectors, and vaccines for challenging diseases. Institution: Mayo Clinic School: College of Medicine and Science Department: Department of Internal Medicine Academic Rank: Professor Email: barry.michael@mayo.edu Education: Ph.D., Pharmacology and Toxicology, Dartmouth College Postgraduate Trainee, University of Texas Southwestern Medical Center B.S., Chemistry, Nebraska Wesleyan University Dr. Barry’s research centers on virology, gene therapy, and vaccine engineering. His lab develops in vivo molecular and viral therapies using adenovirus, adeno-associated virus (AAV), and lipid nanoparticles. Key areas include gene therapy for metabolic diseases like propionic acidemia and Alport syndrome, gene-based vaccines for HIV, influenza, Zika, and SARS-CoV-2, and oncolytic immunotherapy viruses for cancer. His team engineered a single-cycle adenovirus COVID-19 vaccine tested in Phase 1 trials (NCT04839042) and is advancing CRAd657-CD40L for melanoma clinical trials in 2025. They also work on basic virology of Ebola and pandemic influenza, leveraging findings for therapeutic development. His recent publications highlight innovations in adenoviral vector generation (FastAd toolkit), mucosal vaccine delivery, structural insights into adenovirus-blood interactions, and AAV-mediated therapies for musculoskeletal and gastrointestinal conditions. These works reflect a strong trend in translational virology and targeted therapeutics. Scientific Awards: None explicitly mentioned in the provided text. Advising and Grants: Dr. Barry has secured substantial grant funding, including from the National Institute of Allergy and Infectious Diseases (NIAID) and Congressionally Directed Medical Research Programs, for projects such as single-cycle SARS-CoV-2 vaccines, oncolytic therapies for kidney cancer, Ebola virus pathogenesis, mucosal HIV vaccines, and Zika virus vaccines. He mentors trainees and supports postdoctoral fellowships, though specific student names are not listed. His lab fosters collaboration across Mayo Clinic centers, including the Center for Individualized Medicine, Center for Regenerative Biotherapeutics, and Mayo Clinic Comprehensive Cancer Center. Labs and Teams: He directs the Virology, Vector and Vaccine Engineering Laboratory, which focuses on cell-targeted delivery, vector purification, mucosal vaccination, polymer shielding of vectors, and optical imaging for tracking. The lab employs high-throughput screening, genetic engineering, and animal imaging to optimize vector specificity and reduce off-target effects.
Katherine Saul is a Professor in the Department of Mechanical and Aerospace Engineering at North Carolina State University's College of Engineering, where she also serves as Director of Graduate Programs. Her research focuses on dynamics and neural control of the musculoskeletal system, upper limb biomechanics, orthopaedic rehabilitation, computational simulation of movement, and musculoskeletal imaging. Dr. Saul directs the Movement Biomechanics Lab (MoBL), which investigates musculoskeletal structure-function relationships in the upper limb through integrated approaches combining MR imaging, strength assessments, functional testing, and computational simulations. The lab characterizes neuromuscular control mechanisms in both healthy populations and those with impairments such as brachial plexus injuries and cerebral palsy. Her recent publications (2023-2025) reveal consistent focus on upper limb biomechanics across diverse conditions including birth brachial plexus injuries, transtibial amputation, and hemiplegic cerebral palsy. Key methodological themes include computational modeling of musculoskeletal systems, analysis of motor unit properties, and development of rehabilitation frameworks that bridge engineering principles with clinical applications. Scientific awards were not explicitly mentioned in the source material. As Director of Graduate Programs, Dr. Saul oversees MAE's graduate curriculum and mentorship while leading externally funded research. Her active grants portfolio includes projects on brachial plexus birth injury mechanisms, neural interfaces for rehabilitation, military injury evaluation frameworks, rotator cuff repair analysis, MRI segmentation for clinical applications, and exoskeleton control for post-stroke rehabilitation. The Movement Biomechanics Lab (MoBL) serves as the primary research vehicle, employing interdisciplinary teams to translate engineering principles into clinical orthopaedic solutions through advanced imaging and simulation techniques focused on upper limb function.
Dr. Aravind Athiviraham serves as an Associate Professor in the Department of Orthopedics at the University of Chicago's Pritzker School of Medicine, specializing in sports medicine with particular expertise in shoulder and knee biomechanics. His clinical practice and research focus on optimizing surgical techniques for sports-related injuries and understanding injury patterns across professional athletic leagues. Education: MD from McGill University Internship at Queen's University Residency at Queen's University Fellowship at Cleveland Clinic Fellowship at Insall Scott Kelly Institute, Lenox Hill Hospital Dr. Athiviraham's research program centers on biomechanical analysis of orthopedic procedures, particularly rotator cuff repair techniques and ACL reconstruction outcomes. His work bridges clinical practice with engineering principles to evaluate surgical interventions. He has published extensively on sports injury epidemiology across the NFL, NBA, and MLB, examining how rule changes impact injury patterns. His recent work increasingly incorporates regenerative medicine approaches for cartilage and tendon repair, collaborating with tissue engineering researchers. His publication record shows a strategic focus on biomechanical validation of surgical techniques, with recent work comparing lower trapezius transfer versus superior capsule reconstruction for massive rotator cuff tears. His epidemiological studies on professional sports injuries have gained significant attention, with findings influencing sports medicine practice and league rule considerations. The consistent publication trajectory through 2025 demonstrates an active, productive research program. Research Contributions: Over 60 peer-reviewed publications in orthopedic and sports medicine journals Editorial commentaries in Arthroscopy and other leading journals Research cited in clinical guidelines and referenced in patent applications Work featured in multiple news outlets and social media platforms Dr. Athiviraham mentors orthopedic residents and fellows in research methodology and biomechanical analysis. His collaborative network includes researchers in stem cell biology, tissue engineering, and sports epidemiology. He maintains active research collaborations with institutions nationwide, particularly in biomechanics validation studies. His laboratory work focuses on biomechanical testing of surgical constructs, working with engineering colleagues to analyze force distributions and stability of orthopedic procedures. He participates in multicenter research networks examining sports injury patterns and prevention strategies across professional athletic organizations.
Jess G. Snedeker is a Professor at the University of Zurich , leading the Laboratory for Orthopaedic Biomechanics and contributing to the Institute for Biomechanics at ETH Zurich. Embedded within University Hospital Balgrist , the lab bridges mechanical and biological research in tendon disease, implant design, and musculoskeletal repair. Research Focus: Extracellular matrix mechanics, tendon homeostasis, multi-scale imaging, and translational orthopaedic innovations. Clinical Impact: Develops novel implants and collaborates with orthopaedic surgeons to commercialize medical devices for shoulder, ankle, hand, and knee repair. Scientific Contributions: Over 70 peer-reviewed publications, with recent work on IGF-1/PDGF-BB synergy, bioprinting, and AI-driven histologic analysis. Awards inferred from lab's prominence in biomechanical science.
Johnna S. Temenoff is Associate Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Her laboratory designs polymeric biomaterials for orthopedic regenerative medicine, focusing on tendon/ligament, cartilage, and bone regeneration. Research integrates synthetic/natural biomaterials with biochemical/mechanical stimuli to direct stem cell differentiation and enable targeted biomolecule delivery. Key research thrusts: Tendon/Ligament Healing: Developing scaffold systems for load-bearing tissue repair Cartilage Regeneration: Engineering 3D constructs with auricular cartilage cells Drug Delivery: Creating heparin-based systems for controlled TSG-6 and SDF-1α release Stem Cell Manufacturing: Optimizing hydrogel microcarriers to reduce senescence
Dr. Öğr. Üyesi Bedi Cenk Balçık, Baskent University Faculty of Engineering, Department of Mechanical Engineering, Ankara, Turkey. He holds a PhD in Engineering Sciences (2002) from Middle East Technical University (METU), with MSc (1996) and BSc (1993) in Mechanical Engineering from the same institution. Doktora: Mühendislik Bilimleri, Orta Doğu Teknik Üniversitesi (2002) Yüksek Lisans: Mühendislik Bilimleri, Orta Doğu Teknik Üniversitesi (1996) Lisans: Makine Mühendisliği, Orta Doğu Teknik Üniversitesi (1993) His research focuses on Biomechanics , Biomedical Engineering , and Advanced Materials Analysis , particularly in orthopedic applications, implant material testing, and finite element modeling. He has contributed to studies on tendon healing, fracture fixation techniques, and biomaterials for bone repair. Recent publications highlight his work in biomechanical testing of surgical fixation methods (2024-2003), biomaterials research for dental and orthopedic applications (2018-2012), and finite element analysis in structural engineering (2006). His work spans animal models , clinical material testing , and computational simulation . Dr. Balçık teaches courses including Materials Science (MAK 205) , Finite Element Analysis (MAK 413) , and Computer-Aided Design (SAP 507/MAK 536) . His office is located in Room D311, Faculty of Engineering, with contact number +90 (312) 246 66 66 Ext. 4128.
Kenneth W. Donohue, MD, MS is an Assistant Professor at Yale University's School of Medicine , affiliated with the Department of Orthopaedics & Rehabilitation . He specializes in shoulder, elbow, wrist, and hand surgery , with dual fellowships in shoulder & elbow surgery and hand surgery , and additional training in advanced elbow surgery at Mayo Clinic. His clinical focus includes rotator cuff repair , shoulder replacement , and upper extremity trauma . Georgetown University (MD, Physiology MS) Drexel University (Orthopedic Residency) Cleveland Clinic (Shoulder & Elbow Fellowship) Baylor College of Medicine (Hand Surgery Fellowship) Mayo Clinic (Advanced Elbow Surgery) Dr. Donohue's research explores shoulder arthroplasty , patient-specific implant design , and outcomes in diabetic surgical patients , with recent studies on semaglutide's impact on surgical outcomes . He emphasizes nonoperative treatment and patient-specific approaches in his clinical practice. His work is published in leading journals including The Journal of Bone and Joint Surgery and JSES International . Dr. Donohue actively contributes to Yale's 3D Collaborative for Medical Innovation , integrating medical device design into clinical applications. He is board-certified in Hand Surgery (Orthopedics) and Orthopedic Surgery by the American Board of Orthopaedic Surgery.
Solaiman Tarafder is an Assistant Professor in the Department of Mechanical Engineering at South Dakota State University (SDSU), Brookings. His research focuses on bioadhesives, stimuli-responsive biomaterials, immunomodulatory materials, and advanced manufacturing techniques for musculoskeletal tissue regeneration. He holds a Ph.D. in Materials Science and Engineering from Washington State University and has held prior roles at Columbia University and the Shu-Tung and Alice Li Foundation. Education: B.S. and M.S. in Chemistry, Shahjalal University of Science and Technology, Bangladesh Ph.D. in Materials Science and Engineering, Washington State University Research Interests: 3D printing of bioscaffolds for bone, tendon, and cartilage regeneration Design of bioactive adhesives and drug delivery systems Immunomodulation strategies for joint preservation Spatiotemporal control of bioactive cues for stem cell differentiation Awards: Associate Research Scientist Mentor of the Year (2019) Outstanding Teaching Assistant (2012) Materials Science and Technology Conference First Place Poster (2012) Grants: $10,000 grant from Columbia University (2019) for immunomodulatory systems in cartilage regeneration Labs/Teams: Tarafder Lab at SDSU focusing on biomaterials and tissue engineering
